General MedicationsINTRAVENOUSGeneric
VENOFER
IRON SUCROSE
Standard Dose
EQ 65MG IRON/3.25ML (EQ 20MG IRON/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Discontinued
Summary
Approval overview VENOFER is listed in Drugs@FDA under application 021135 (NDA).
Review priority: N/A Marketing status: Discontinued Active ingredient IRON SUCROSE Form and strength INJECTABLE;INTRAVENOUS - EQ 65MG IRON/3.25ML (EQ 20MG IRON/ML) Sponsor AM REGENT Submission history Latest submission status date: 2026-03-02 00:00:00.
Structured Monograph
Clinical summary
Approval overview VENOFER is listed in Drugs@FDA under application 021135 (NDA). Review priority: N/A Marketing status: Discontinued Active ingredient IRON SUCROSE Form and strength INJECTABLE;INTRAVENOUS - EQ 65MG IRON/3.25ML (EQ 20MG IRON/ML) Sponsor AM REGENT Submission history Latest submission status date: 2026-03-02 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: N/A
Interaction Notes
- No interaction notes stored yet.